Skip to main
LNSR

LENSAR Inc (LNSR) Stock Forecast & Price Target

LENSAR Inc (LNSR) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

LENSAR is making significant strides in the ophthalmic medical device market with their femtosecond laser system for cataract surgery. With strong financials and a growing install base, they are well-positioned for continued success. The failed acquisition by Alcon may provide an opportunity for other companies to respond and potentially lead to increased competition in the market. However, we believe that LENSAR's innovative technology and focus on recurring revenue will drive future growth and justify a higher valuation compared to its peers.

Bears say

LENSAR is facing significant challenges in the market and its future revenue streams due to lower growth projections and higher operating spend. With flat revenue in FY26 and further decline in FY27 and FY28, their ALLY pricing changes and thinner margins will make it difficult for them to remain competitive in the ophthalmic industry. Despite a strong initial performance, the terminated acquisition by ALC and the need for a priority credit line agreement to stay afloat raises concerns about their ability to continue operations in the long term.

LENSAR Inc (LNSR) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of LENSAR Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About LENSAR Inc (LNSR) Forecast

Analysts have given LENSAR Inc (LNSR) a Strong Buy based on their latest research and market trends.

According to 1 analysts, LENSAR Inc (LNSR) has a Strong Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

LENSAR Inc (LNSR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.